Medication Class News Today

Common Warts IndustryIn 2023 to 2033, the global common warts industry size is expected to increase at a 3.6% CAGR, according to a new FMI report. It is projected that the market will be worth US$ 1,100 million by the end of the previously indicated evaluation period. Increased pharmaceutical R&D activities for the...

/PRNewswire/ -- Allied Market Research published a report, titled, "Interventional Pulmonology Market by Product (Bronchoscopes, Electromagnetic Navigation...

A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts...

A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts...

North America Common Warts Market is expected to grow at a CAGR of 3.5% in the assessment period 2023-2033. The Asia Pacific is expected to grow at a CAGR...

/PRNewswire/ -- The "Global HIV/AIDS Drugs Market (2022-2027) by Medication Class, Distribution Channel, Geography, Competitive Analysis and the Impact of...

/PRNewswire/ -- The "Asthma and COPD Drugs Market by Diseases and Medication Class (Combination Drugs, Inhaled Corticosteroids, Short Acting Beta Agonists,...

Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "Asthma and COPD Drugs Market by Diseases and Medication Class (Combination Drugs, Inhaled Corticosteroids,...